1555 studies found for:    Open Studies | "Kidney Diseases"
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
2 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
3 Recruiting Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Conditions: Diabetic Nephropathy;   Diabetes Mellitus;   Diabetic Kidney Disease;   Albuminuria
Intervention:
4 Unknown  Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Intervention: Drug: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE
5 Recruiting Repository Study of Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
6 Recruiting Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Conditions: Chronic Renal Failure;   Polycystic Kidney Disease
Intervention: Biological: Intravenous injection autologous mesenchymal stem cells
7 Unknown  Risk Stratification in End Stage Renal Disease (ESRD)
Conditions: End Stage Renal Disease;   Chronic Kidney Disease;   Cardiovascular Event;   Sudden Cardiac Death
Intervention:
8 Not yet recruiting Lanreotide In Polycystic Kidney Disease Study
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions: Drug: Lanreotide;   Drug: saline
9 Recruiting Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Conditions: Anemia;   Chronic Kidney Disease;   Kidney Disease
Interventions: Drug: darbepoetin alfa QW;   Drug: darbepoetin alfa Q2W
10 Recruiting Pilot Study of Velcade® in IgA Nephropathy
Conditions: Chronic Kidney Disease;   IgA Nephropathy
Intervention: Drug: Bortezomib (Velcade®)
11 Recruiting Improving Evidence-Based Primary Care for Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Chronic Kidney Insufficiency;   Chronic Renal Diseases;   Chronic Renal Insufficiency;   Kidney Insufficiency, Chronic
Interventions: Other: Facilitated Clinical Decision Support;   Other: Clinical Decision Support Only
12 Recruiting Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
Conditions: Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 3
Intervention: Drug: Aspirin
13 Not yet recruiting The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Everolimus;   Drug: Calcineurin inhibitors maintenance
14 Recruiting Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting
Conditions: End Stage Renal Disease;   Kidney Disease;   Protein Energy Wasting
Interventions: Drug: PINTA 745;   Drug: Placebo
15 Recruiting N-Acetyl Cystein and Contrast Nephropathy
Conditions: Chronic Kidney Disease Stage 2;   Radiographic Contrast Agent Nephropathy
Interventions: Drug: Oral N-Acetyl Cystein;   Drug: IV N-Acetyl Cystein;   Drug: Placebo group
16 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
Intervention:
17 Recruiting Kidney Disease Biomarkers
Conditions: Kidney Disease;   Glomerular Disease;   Idiopathic Nephrotic Syndrome;   Focal Segmental Glomerulosclerosis;   Collapsing Glomerulopathy
Intervention:
18 Recruiting Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Conditions: Kidney Diseases;   Kidney Failure, Chronic;   Diabetic Nephropathy;   Lupus Nephritis;   Glomerulonephritis, IGA
Intervention:
19 Recruiting Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Intervention: Dietary Supplement: Niacinamide
20 Unknown  Impact of Vitamin D on Diabetic Kidney Disease in African Americans
Condition: Diabetic Kidney Disease
Intervention: Drug: Vitamin D3

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years